Quarterly Revenue and Profit Acceleration
Group revenues +8% in Q4 2025; net profit +28% year-over-year, approaching EUR 3.0 billion (record Q4). Jaws effect +2.9 points (3.9 points excluding AXA IM).
We use cookies to improve your experience, analyze site usage, and show relevant ads. Go to our Privacy Policy for details.
The call highlighted a clear acceleration in revenues and profits, strengthened three-year financial targets and a concrete plan to improve efficiency (including a structural support-function transformation and quantified AI benefits). Capital and asset-quality trends are constructive but the CET1 ratio remains below the 13% target and the Corporate Center / restructuring costs are a meaningful near-term drag. On balance, positive top-line momentum, delivered cost savings, and a credible medium-term profitability trajectory outweigh the near-term headwinds.
BNP Paribas guided to continued momentum: Q4 revenues +8% (CIB +1% / +4.8% at constant scope, CPBS +5.5%, IPS +11% organic and ~+40% including AXA IM), net profit +28% to ~€3bn, CET1 12.6% (+10bps) with a 13% target (aiming to reach it by end‑'27 after a 30bps FRTB assumption), and a 2025 dividend per share of €5.16 (final €2.57). Management reconfirmed >7% earnings and 8% EPS CAGR for ’24–’26, targets 12% RoTE in ’26 and >13% in ’28 (and >10% earnings CAGR / sharper EPS CAGR for ’25–’28), expects to deliver a 1.5pp jaws effect, keep cost of risk below 40bps, and cut the cost‑to‑income ratio from ~58% to <56% by ’28 building on €3.5bn savings (completed by end‑’26) plus a new support‑functions program covering ~€15bn of costs with first benefits from ’27; they also expect AI benefits of ~€600m to date (rising to €750m by ’26), confirm a ≥60% payout (not less than 60% for ’27–’30), plan disposals to free 30–50bps of CET1, and have corporate‑center restructuring ~€800m and central costs ~€600m in 2026 (gross operating loss ≈€1.4bn).
Group revenues +8% in Q4 2025; net profit +28% year-over-year, approaching EUR 3.0 billion (record Q4). Jaws effect +2.9 points (3.9 points excluding AXA IM).
CIB revenues +1% in Q4 (≈+4.8% at constant FX); CPBS revenues +5.5%; IPS delivered double-digit organic growth (+11% excl. AXA IM; ≈+40% including AXA IM integration).
CET1 ratio reached 12.6% (up 10 bps quarter-on-quarter). Management reconfirms target CET1 13% (end-2027 objective) and payout policy of ≥60% (EUR 5.16 dividend per share for 2025 including EUR 2.57 final).
Cost of risk remained low at 34 basis points in Q4 (within guidance <40 bps); Stage 3 provisions lower than Q4 2024 and portfolio described as well positioned.
Return on tangible equity target increased from 13% to above 13% by 2028; guidance reconfirmed for >7% earnings CAGR and ~8% EPS CAGR over 2024–2026; RoTE 12% targeted for 2026 as step to >13% in 2028.
Cost-to-income outlook improved from ~58% to <56% by 2028. Announced a new structural transformation plan for support functions aiming to optimize ~EUR 15 billion of spend; first benefits starting 2027.
AI-related benefits quantified at ≈EUR 600 million to date and expected to reach EUR 750 million by 2026; management positions BNP Paribas as leading Eurozone bank on Evident AI Index.
EUR 3.5 billion cost savings program to be completed by end-2026 (EUR 2.9 billion achieved since 2021); demonstrated positive jaws across divisions and 2.7 points of jaws in H2 2025, above the 2.5-point target.
Good afternoon, ladies and gentlemen, and welcome to the presentation of the BNP Paribas Fourth Quarter and Full Year 2025 results with Jean-Laurent Bonnafe, Group Chief Executive Officer; and Lars Machenil, Group Chief Financial Officer. For your information, this conference call is being recorded. Supporting slides are available on BNP Paribas IR website, invest.bnpparibas.com. [Operator Instructions] I would like now to hand the call over to Jean-Laurent Bonnafe, Group Chief Executive Officer. Please go ahead, sir.
Good afternoon, ladies and gentlemen. We are pleased to present today our strong fourth quarter results, and we'll provide some elements on our '28 trajectory, which we are revising upwards given the strong revenue momentum at the launch of a transformation plan of our support functions. I will start with our results on Slide 4. So our fourth quarter results confirmed the sharp acceleration we had expected. Revenues posted a strong 8% growth. Jaws effect was higher at 2.9 points and even reached 3.9 points when excluding AXA IM. Cost of fees stayed low at 34 bps well within our trajectory of below 40 bps. And this led to a very strong 28% increase in net profit, approaching EUR 3 billion, which is a record for our fourth quarter.
Our CET1 reached 12.6%, up 10 bps this quarter, and we remain committed to delivering on our target of 13%. For '25, we will have paid a total dividend per share of EUR 5.16 including the final dividend of EUR 2.57 to be paid in May. If we focus on our revenues, they are up 8% with well-balanced growth between the businesses. CIB reve...
February 5th, 2026
July 24th, 2025
April 24th, 2025
February 4th, 2025
October 31st, 2024
July 24th, 2024
April 25th, 2024
February 1st, 2024
October 26th, 2023
July 27th, 2023